Eon Labs reported last month that a federal trial in a patent infringement case brought by Novartis against Eon's cyclosporine USP modified softgel capsules has been cancelled. The court had not issued an order explaining its reasoning as of late last month, but Eon said its outside counsel was advised that the court intended to grant summary judgment against Novartis on its infringement claim. Teva Pharmaceuticals USA has introduced cefaclor extended-release tablets in 375 mg and 500 mg. Cefaclor is AB rated and bioequivalent to Lilly's Ceclor antibiotic.
COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2002 Gale Group
Home
A
Cabergoline
